MetaVia Inc. (MTVA)
$1.36-4.90%Close
SELLCRISIS · day 11
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- 0.96
- P/E (TTM)
- -0.33
- Short % float
- 11.96%
- Days to cover
- 2.0
- SI change
- -36.0%
- 1W
- -6.85%
- 1M
- -13.92%
- vs SPY 1W
- -6.71%
- vs SPY 1M
- -16.43%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on MTVA?
- LOPJLB’s latest quantitative signal on MetaVia Inc. (MTVA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is MTVA in?
- MetaVia Inc. (MTVA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does MetaVia Inc. (MTVA) do?
- Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading investigational drug, DA-1241, a unique G-Protein-Coupled Receptor 119 agonist, is currently undergoing Phase 2a clinical trials for metabolic dysfunction-associat…